Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADAM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GFRA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGLEC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPA12B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C20orf27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC25B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C20orf194 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on